Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Baozun Inc.

43.5% sales growth and 8.13% return on equity

Baozun Inc. provides e-commerce solutions to brand partners in the People's Republic of China.

Baozun Inc.’s sales growth this year is anticipated to be 32.4% and 28.8% for next year.

Year-on-year quarterly revenue growth grew by 21.7%, now sitting on N/A for the twelve trailing months.

Baozun Inc.’s sales growth for the next quarter is 43.5%. The company’s growth estimates for the current quarter and the next is 42.1% and 100%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.

Baozun Inc.’s Stock Yearly Top and Bottom Value

Baozun Inc.’s stock is valued at $35.63 at 01:22 EST, way below its 52-week high of $47.51 and way above its 52-week low of $22.19.

Baozun Inc.’s Moving Average

Baozun Inc.’s value is below its 50-day moving average of $38.49 and below its 200-day moving average of $38.10.

2. United Bankshares, Inc.

44.9% sales growth and 6.82% return on equity

United Bankshares, Inc., a financial holding company, primarily provides commercial and retail banking products and services in the United States.

United Bankshares, Inc.’s sales growth this year is anticipated to be 38.3% and a negative 3.4% for next year.

Year-on-year quarterly revenue growth grew by 69.6%, now sitting on 837.89M for the twelve trailing months.

United Bankshares, Inc.’s sales growth for the next quarter is 44.9%. The company’s growth estimates for the current quarter and the next is a negative 8.1% and 47.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.82%.

United Bankshares, Inc.’s Stock Yearly Top and Bottom Value

United Bankshares, Inc.’s stock is valued at $30.53 at 01:22 EST, way under its 52-week high of $39.11 and way higher than its 52-week low of $19.67.

United Bankshares, Inc.’s Moving Average

United Bankshares, Inc.’s value is above its 50-day moving average of $28.98 and way higher than its 200-day moving average of $26.96.

3. Agree Realty Corporation

30.3% sales growth and 4.84% return on equity

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants.

Agree Realty Corporation’s sales growth this year is expected to be 31% and 28.8% for next year.

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 229.29M for the twelve trailing months.

Agree Realty Corporation’s sales growth for the next quarter is 30.3%. The company’s growth estimates for the current quarter and the next is a negative 25% and negative -13%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.84%.

Agree Realty Corporation’s Stock Yearly Top and Bottom Value

Agree Realty Corporation’s stock is valued at $63.99 at 01:22 EST, way under its 52-week high of $80.51 and way above its 52-week low of $45.23.

Agree Realty Corporation’s Moving Average

Agree Realty Corporation’s value is below its 50-day moving average of $65.49 and below its 200-day moving average of $65.84.

4. Blueprint Medicines Corporation

461.9% sales growth and 36.29% return on equity

Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy.

Blueprint Medicines Corporation’s sales growth this year is anticipated to be 1077.3% and a negative 79.5% for next year.

Year-on-year quarterly revenue growth grew by 8053.2%, now sitting on 811.16M for the twelve trailing months.

Blueprint Medicines Corporation’s sales growth for the next quarter is 461.9%. The company’s growth estimates for the current quarter and the next is a negative 28.1% and 25.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.29%.

Blueprint Medicines Corporation’s Stock Yearly Top and Bottom Value

Blueprint Medicines Corporation’s stock is valued at $117.31 at 01:22 EST, under its 52-week high of $119.66 and way above its 52-week low of $43.29.

Blueprint Medicines Corporation’s Moving Average

Blueprint Medicines Corporation’s value is way higher than its 50-day moving average of $103.25 and way above its 200-day moving average of $85.87.

5. Zynex, Inc.

86.2% sales growth and 28.99% return on equity

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Zynex, Inc.’s sales growth this year is anticipated to be 76.3% and 78.2% for next year.

Year-on-year quarterly revenue growth grew by 69.5%, now sitting on 68.68M for the twelve trailing months.

Zynex, Inc.’s sales growth for the next quarter is 86.2%. The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and negative -11.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.99%.

Zynex, Inc.’s Stock Yearly Top and Bottom Value

Zynex, Inc.’s stock is valued at $14.00 at 01:22 EST, way below its 52-week high of $29.73 and way above its 52-week low of $7.51.

Zynex, Inc.’s Moving Average

Zynex, Inc.’s worth is higher than its 50-day moving average of $13.55 and way below its 200-day moving average of $17.59.

6. PulteGroup, Inc.

23.8% sales growth and 22.84% return on equity

PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States.

PulteGroup, Inc.’s sales growth this year is anticipated to be 7.1% and 20% for next year.

Year-on-year quarterly revenue growth grew by 9%, now sitting on 10.86B for the twelve trailing months.

PulteGroup, Inc.’s sales growth for the next quarter is 23.8%. The company’s growth estimates for the ongoing quarter and the next is 13.1% and 44.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.84%.

PulteGroup, Inc.’s Stock Yearly Top and Bottom Value

PulteGroup, Inc.’s stock is valued at $45.10 at 01:22 EST, below its 52-week high of $49.70 and way above its 52-week low of $17.12.

PulteGroup, Inc.’s Moving Average

PulteGroup, Inc.’s worth is higher than its 50-day moving average of $43.23 and higher than its 200-day moving average of $42.26.

7. Coastal Financial Corporation

27.2% sales growth and 11.02% return on equity

Coastal Financial Corporation operates as the bank holding company for Coastal Community Bank that provides various banking products and services to consumers and small to medium sized businesses in the Puget Sound region in Washington.

Coastal Financial Corporation’s sales growth this year is expected to be 27% and 9.1% for next year.

Year-on-year quarterly revenue growth grew by 21.8%, now sitting on 53.33M for the twelve trailing months.

Coastal Financial Corporation’s sales growth for the next quarter is 27.2%. The company’s growth estimates for the ongoing quarter and the next is 23.3% and 45.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.02%.

Coastal Financial Corporation’s Stock Yearly Top and Bottom Value

Coastal Financial Corporation’s stock is valued at $22.01 at 01:22 EST, below its 52-week high of $23.05 and way higher than its 52-week low of $8.41.

Coastal Financial Corporation’s Moving Average

Coastal Financial Corporation’s worth is way above its 50-day moving average of $18.64 and way higher than its 200-day moving average of $15.07.

8. First American Corporation

5.7% sales growth and 14.34% return on equity

First American Financial Corporation, through its subsidiaries, provides financial services.

First American Corporation’s sales growth this year is anticipated to be 9.8% and a negative 5.7% for next year.

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 6.66B for the twelve trailing months.

First American Corporation’s sales growth for the next quarter is 5.7%. The company’s growth estimates for the ongoing quarter and the next is a negative 15% and negative -15.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.

First American Corporation’s Stock Yearly Top and Bottom Value

First American Corporation’s stock is valued at $53.16 at 01:22 EST, way under its 52-week high of $66.78 and way above its 52-week low of $29.36.

First American Corporation’s Moving Average

First American Corporation’s value is above its 50-day moving average of $49.37 and higher than its 200-day moving average of $50.91.

LEAVE A REPLY

Please enter your comment!
Please enter your name here